Immunological Change and the Single Nucleotide Polymorphism (SNP) in Children With Irritable Bowel Syndrome (IBS)
NCT01131442 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2010-05-27
Summary
Currently, the pathophysiology of Irritable bowel syndrome( IBS) remains unclear . The purpose of this study is want to investigate the immunological changes in the children with IBS.
Conditions
- Irritable Bowel Syndrome
- Children
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 5 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-11-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS
NCT03675100 ·Status: COMPLETED ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
NCT02566629 ·Status: UNKNOWN
-
Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
NCT01854060 ·Status: COMPLETED
-
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903 ·Status: COMPLETED
-
Genetic Contribution of Pain and Inflammation in IBS
NCT01436760 ·Status: COMPLETED
-
Diet and Motility in IBS
NCT07283341 ·Status: RECRUITING
-
Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 ·Status: COMPLETED
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome
NCT00659763 ·Status: COMPLETED
-
Colonoscopic Probiotics Spray in Irritable Bowel Syndrome
NCT05864716 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
NCT02249169 ·Status: COMPLETED
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome
NCT01632488 ·Status: UNKNOWN
-
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
NCT02981888 ·Status: COMPLETED
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Direct Medical Costs Associated With Negative Diagnosis of IBS.
NCT05144594 ·Status: UNKNOWN
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
NCT02693730 ·Status: COMPLETED
-
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome
NCT01028898 ·Status: UNKNOWN
-
IBS-C Questionnaire Study
NCT04968652 ·Status: COMPLETED
-
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316 ·Status: COMPLETED
-
Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis
NCT05311293 ·Status: UNKNOWN
-
Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China
NCT01060527 ·Status: UNKNOWN
-
Effect of Pentoxifylline on Tight Junctions (TJs) of Intestinal Mucosa in Patients With Irritable Bowel Syndrome(IBS)
NCT01542268 ·Status: UNKNOWN ·Phase: PHASE4